Koss-Olinger Consulting »

Crispr Therapeutics shares owned by Koss-Olinger Consulting

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Koss-Olinger Consulting from 13F filings

Historical chart of Koss-Olinger Consulting investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Koss-Olinger Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Koss-Olinger Consulting

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.1M 25k 45.39
2023-06-30 $1.2M 22k 56.14
2023-03-31 $972k 22k 45.21
2021-06-30 $2.0M 13k 161.90
2021-03-31 $1.4M 11k 121.87